{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T10:33:05Z","timestamp":1786962785023,"version":"build-2736575974"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100009110","name":"Natural Science Foundation of Xinjiang Uygur Autonomous Region","doi-asserted-by":"crossref","award":["2023D01C97"],"award-info":[{"award-number":["2023D01C97"]}],"id":[{"id":"10.13039\/100009110","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Special Funds for Development of Local Science and Technology from Central Government","award":["ZYYD2022B06"],"award-info":[{"award-number":["ZYYD2022B06"]}]},{"DOI":"10.13039\/501100001809","name":"Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81960527"],"award-info":[{"award-number":["81960527"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Innovation Research Group Cultivation Program","award":["xyd2021C001"],"award-info":[{"award-number":["xyd2021C001"]}]},{"name":"Key Research and Development Project of the Xinjiang Uygur Autonomous Region","award":["2020B03003-1"],"award-info":[{"award-number":["2020B03003-1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-05649-y","type":"journal-article","created":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T03:42:39Z","timestamp":1751427759000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["PSD3, regulated by PKM2, endows growth and metastasis advantages in esophageal squamous cell carcinoma by modulating EMT progression"],"prefix":"10.1038","volume":"15","author":[{"given":"Qiqi","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shutao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"5649_CR1","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2020.0140","author":"X Wu","year":"2021","unstructured":"Wu, X., Zhang, H., Sui, Z., Wang, Y. & Yu, Z. The biological role of the CXCL12\/CXCR4 axis in esophageal squamous cell carcinoma. Cancer Biology Med. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2020.0140 (2021).","journal-title":"Cancer Biology Med."},{"key":"5649_CR2","doi-asserted-by":"publisher","unstructured":"Wu, H. et al. Clinical benefit of First-Line programmed death-1 antibody plus chemotherapy in low programmed cell death ligand 1-Expressing esophageal squamous cell carcinoma: A post hoc analysis of JUPITER-06 and Meta-Analysis. J. Clin. Oncology: Official J. Am. Soc. Clin. Oncol. JCO2201490 https:\/\/doi.org\/10.1200\/jco.22.01490 (2022).","DOI":"10.1200\/jco.22.01490"},{"key":"5649_CR3","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/jjco\/hyz034","volume":"49","author":"H Hirano","year":"2019","unstructured":"Hirano, H. & Kato, K. Systemic treatment of advanced esophageal squamous cell carcinoma: chemotherapy, molecular-targeting therapy and immunotherapy. Jpn J. Clin. Oncol. 49, 412\u2013420. https:\/\/doi.org\/10.1093\/jjco\/hyz034 (2019).","journal-title":"Jpn J. Clin. Oncol."},{"key":"5649_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1620\/tjem.214.191","volume":"214","author":"H Sakagami","year":"2008","unstructured":"Sakagami, H. The EFA6 family: guanine nucleotide exchange factors for ADP ribosylation factor 6 at neuronal synapses. Tohoku J. Exp. Med. 214, 191\u2013198. https:\/\/doi.org\/10.1620\/tjem.214.191 (2008).","journal-title":"Tohoku J. Exp. Med."},{"key":"5649_CR5","doi-asserted-by":"publisher","first-page":"33378","DOI":"10.1074\/jbc.M113.534156","volume":"289","author":"V Kanamarlapudi","year":"2014","unstructured":"Kanamarlapudi, V. Exchange factor EFA6R requires C-terminal targeting to the plasma membrane to promote cytoskeletal rearrangement through the activation of ADP-ribosylation factor 6 (ARF6). J. Biol. Chem. 289, 33378\u201333390. https:\/\/doi.org\/10.1074\/jbc.M113.534156 (2014).","journal-title":"J. Biol. Chem."},{"key":"5649_CR6","doi-asserted-by":"publisher","first-page":"14919","DOI":"10.1038\/srep14919","volume":"5","author":"R Okada","year":"2015","unstructured":"Okada, R. et al. Activation of the small G protein Arf6 by Dynamin2 through guanine nucleotide exchange factors in endocytosis. Sci. Rep. 5, 14919. https:\/\/doi.org\/10.1038\/srep14919 (2015).","journal-title":"Sci. Rep."},{"key":"5649_CR7","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.4049\/jimmunol.169.2.1102","volume":"169","author":"Y Wang","year":"2002","unstructured":"Wang, Y. et al. Large scale identification of human hepatocellular carcinoma-associated antigens by autoantibodies. J. Immunol. (Baltimore Md. : 1950). 169, 1102\u20131109. https:\/\/doi.org\/10.4049\/jimmunol.169.2.1102 (2002).","journal-title":"J. Immunol. (Baltimore Md. : 1950)"},{"key":"5649_CR8","doi-asserted-by":"publisher","first-page":"7925","DOI":"10.1038\/ncomms8925","volume":"6","author":"T Hongu","year":"2015","unstructured":"Hongu, T. et al. Arf6 regulates tumour angiogenesis and growth through HGF-induced endothelial \u03b21 integrin recycling. Nat. Commun. 6, 7925. https:\/\/doi.org\/10.1038\/ncomms8925 (2015).","journal-title":"Nat. Commun."},{"key":"5649_CR9","doi-asserted-by":"publisher","first-page":"5413","DOI":"10.7150\/jca.60885","volume":"12","author":"L Jin","year":"2021","unstructured":"Jin, L. et al. PSD3 is an oncogene that promotes proliferation, migration, invasion, and G1\/S transition while inhibits apoptotic in papillary thyroid cancer. J. Cancer. 12, 5413\u20135422. https:\/\/doi.org\/10.7150\/jca.60885 (2021).","journal-title":"J. Cancer"},{"key":"5649_CR10","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s10549-008-9927-2","volume":"113","author":"M Thomassen","year":"2009","unstructured":"Thomassen, M., Tan, Q. & Kruse, T. Gene expression meta-analysis identifies chromosomal regions and candidate genes involved in breast cancer metastasis. Breast Cancer Res. Treat. 113, 239\u2013249. https:\/\/doi.org\/10.1007\/s10549-008-9927-2 (2009).","journal-title":"Breast Cancer Res. Treat."},{"key":"5649_CR11","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1002\/cncr.21538","volume":"104","author":"D Pils","year":"2005","unstructured":"Pils, D. et al. Five genes from chromosomal band 8p22 are significantly down-regulated in ovarian carcinoma: N33 and EFA6R have a potential impact on overall survival. Cancer 104, 2417\u20132429. https:\/\/doi.org\/10.1002\/cncr.21538 (2005).","journal-title":"Cancer"},{"key":"5649_CR12","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3389\/fonc.2020.00159","volume":"10","author":"K Zahra","year":"2020","unstructured":"Zahra, K., Dey, T., Ashish, Mishra, S. & Pandey, U. Pyruvate kinase M2 and cancer: the role of PKM2 in promoting tumorigenesis. Front. Oncol. 10, 159. https:\/\/doi.org\/10.3389\/fonc.2020.00159 (2020).","journal-title":"Front. Oncol."},{"key":"5649_CR13","doi-asserted-by":"publisher","unstructured":"Puckett, D., Alquraishi, M., Chowanadisai, W. & Bettaieb, A. The role of PKM2 in metabolic reprogramming: insights into the regulatory roles of Non-Coding RNAs. Int. J. Mol. Sci. 22 https:\/\/doi.org\/10.3390\/ijms22031171 (2021).","DOI":"10.3390\/ijms22031171"},{"key":"5649_CR14","doi-asserted-by":"publisher","unstructured":"Wang, C., Wang, J., Chen, Z., Gao, Y. & He, J. Immunohistochemical prognostic markers of esophageal squamous cell carcinoma: a systematic review. Chin. J. cancer. 36 https:\/\/doi.org\/10.1186\/s40880-017-0232-5 (2017).","DOI":"10.1186\/s40880-017-0232-5"},{"key":"5649_CR15","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.18632\/oncotarget.13703","volume":"8","author":"H Zhu","year":"2017","unstructured":"Zhu, H. et al. Pyruvate kinase M2 (PKM2) expression correlates with prognosis in solid cancers: a meta-analysis. Oncotarget 8, 1628\u20131640. https:\/\/doi.org\/10.18632\/oncotarget.13703 (2017).","journal-title":"Oncotarget"},{"key":"5649_CR16","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.28434","author":"R Ma","year":"2019","unstructured":"Ma, R. et al. PKM2-regulated STAT3 promotes esophageal squamous cell carcinoma progression via TGF-\u03b21-induced EMT. J. Cell. Biochem. https:\/\/doi.org\/10.1002\/jcb.28434 (2019).","journal-title":"J. Cell. Biochem."},{"key":"5649_CR17","doi-asserted-by":"publisher","unstructured":"Wang, A., Guo, H. & Long, Z. Integrative analysis of differently expressed genes reveals a 17-Gene prognosis signature for endometrial carcinoma. Biomed. Res. Int. 2021 (4804694). https:\/\/doi.org\/10.1155\/2021\/4804694 (2021).","DOI":"10.1155\/2021\/4804694"},{"key":"5649_CR18","doi-asserted-by":"publisher","first-page":"4277","DOI":"10.2147\/ott.S106508","volume":"9","author":"J Wu","year":"2016","unstructured":"Wu, J. et al. Pyruvate kinase M2 overexpression and poor prognosis in solid tumors of digestive system: evidence from 16 cohort studies. Onco Targets Ther. 9, 4277\u20134288. https:\/\/doi.org\/10.2147\/ott.S106508 (2016).","journal-title":"Onco Targets Ther."},{"key":"5649_CR19","doi-asserted-by":"publisher","first-page":"e8690","DOI":"10.1097\/md.0000000000008690","volume":"96","author":"Y Yang","year":"2017","unstructured":"Yang, Y. et al. Prognostic significance of metabolic enzyme pyruvate kinase M2 in breast cancer: A meta-analysis. Medicine 96, e8690. https:\/\/doi.org\/10.1097\/md.0000000000008690 (2017).","journal-title":"Medicine"},{"key":"5649_CR20","doi-asserted-by":"publisher","first-page":"e25545","DOI":"10.1097\/md.0000000000025545","volume":"100","author":"H Li","year":"2021","unstructured":"Li, H., Yan, M., Wu, X., Wang, Y. & Huang, L. Expression and clinical significance of pyruvate kinase M2 in breast cancer: A protocol for meta-analysis and bioinformatics validation analysis. Medicine 100, e25545. https:\/\/doi.org\/10.1097\/md.0000000000025545 (2021).","journal-title":"Medicine"},{"key":"5649_CR21","doi-asserted-by":"publisher","first-page":"7284","DOI":"10.18632\/aging.202583","volume":"13","author":"Y Wang","year":"2021","unstructured":"Wang, Y. et al. Prognostic value of Glycolysis markers in head and neck squamous cell carcinoma: a meta-analysis. Aging 13, 7284\u20137299. https:\/\/doi.org\/10.18632\/aging.202583 (2021).","journal-title":"Aging"},{"key":"5649_CR22","first-page":"628","volume":"6","author":"M Hsu","year":"2016","unstructured":"Hsu, M. et al. Extracellular PKM2 induces cancer proliferation by activating the EGFR signaling pathway. Am. J. Cancer Res. 6, 628\u2013638 (2016).","journal-title":"Am. J. Cancer Res."},{"key":"5649_CR23","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/s42003-019-0343-4","volume":"2","author":"T Chen","year":"2019","unstructured":"Chen, T. et al. Mutations in the PKM2 exon-10 region are associated with reduced allostery and increased nuclear translocation. Commun. Biology. 2, 105. https:\/\/doi.org\/10.1038\/s42003-019-0343-4 (2019).","journal-title":"Commun. Biology"},{"key":"5649_CR24","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.molcel.2012.01.001","volume":"45","author":"X Gao","year":"2012","unstructured":"Gao, X., Wang, H., Yang, J., Liu, X. & Liu, Z. Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol. Cell. 45, 598\u2013609. https:\/\/doi.org\/10.1016\/j.molcel.2012.01.001 (2012).","journal-title":"Mol. Cell."},{"key":"5649_CR25","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/j.biocel.2010.02.005","volume":"43","author":"S Mazurek","year":"2011","unstructured":"Mazurek, S. Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells. Int. J. Biochem. Cell Biol. 43, 969\u2013980. https:\/\/doi.org\/10.1016\/j.biocel.2010.02.005 (2011).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"5649_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.yexcr.2014.10.020","volume":"330","author":"C Brantis-de-Carvalho","year":"2015","unstructured":"Brantis-de-Carvalho, C. et al. MxA interacts with and is modified by the sumoylation machinery. Exp. Cell. Res. 330, 151\u2013163. https:\/\/doi.org\/10.1016\/j.yexcr.2014.10.020 (2015).","journal-title":"Exp. Cell. Res."},{"key":"5649_CR27","doi-asserted-by":"publisher","first-page":"2976","DOI":"10.1074\/jbc.M609989200","volume":"282","author":"E Cannavo","year":"2007","unstructured":"Cannavo, E., Gerrits, B., Marra, G., Schlapbach, R. & Jiricny, J. Characterization of the interactome of the human MutL homologues MLH1, PMS1, and PMS2. J. Biol. Chem. 282, 2976\u20132986. https:\/\/doi.org\/10.1074\/jbc.M609989200 (2007).","journal-title":"J. Biol. Chem."},{"key":"5649_CR28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1042\/bc20100154","volume":"103","author":"H Yoon","year":"2011","unstructured":"Yoon, H., Kales, S., Luo, R., Lipkowitz, S. & Randazzo, P. ARAP1 association with CIN85 affects epidermal growth factor receptor endocytic trafficking. Biol. Cell. 103, 171\u2013184. https:\/\/doi.org\/10.1042\/bc20100154 (2011).","journal-title":"Biol. Cell"},{"key":"5649_CR29","doi-asserted-by":"publisher","first-page":"e1003151","DOI":"10.1371\/journal.pgen.1003151","volume":"8","author":"L Xie","year":"2012","unstructured":"Xie, L. et al. A synthetic interaction screen identifies factors selectively required for proliferation and TERT transcription in p53-deficient human cancer cells. PLoS Genet. 8, e1003151. https:\/\/doi.org\/10.1371\/journal.pgen.1003151 (2012).","journal-title":"PLoS Genet."},{"key":"5649_CR30","doi-asserted-by":"publisher","unstructured":"Chen, K., Hsu, J. & Lee, F. AMPK promotes Arf6 activation in a kinase-independent manner upon glucose starvation. J. Cell. Sci. 135 https:\/\/doi.org\/10.1242\/jcs.259609 (2022).","DOI":"10.1242\/jcs.259609"},{"key":"5649_CR31","doi-asserted-by":"publisher","unstructured":"Ghosh, M. et al. CD13 tethers the IQGAP1-ARF6-EFA6 complex to the plasma membrane to promote ARF6 activation, \u03b21 integrin recycling, and cell migration. Sci. Signal. 12 https:\/\/doi.org\/10.1126\/scisignal.aav5938 (2019).","DOI":"10.1126\/scisignal.aav5938"},{"key":"5649_CR32","doi-asserted-by":"publisher","first-page":"153303381878006","DOI":"10.1177\/1533033818780063","volume":"17","author":"H Xiaoyu","year":"2018","unstructured":"Xiaoyu, H. et al. The mTOR pathway regulates PKM2 to affect Glycolysis in esophageal squamous cell carcinoma. Technol. Cancer Res. Treat. 17, 1533033818780063. https:\/\/doi.org\/10.1177\/1533033818780063 (2018).","journal-title":"Technol. Cancer Res. Treat."},{"key":"5649_CR33","doi-asserted-by":"publisher","first-page":"3803","DOI":"10.1038\/s41467-021-23501-5","volume":"12","author":"W Wang","year":"2021","unstructured":"Wang, W. et al. METTL3 promotes tumour development by decreasing APC expression mediated by APC mRNA N-methyladenosine-dependent YTHDF binding. Nat. Commun. 12, 3803. https:\/\/doi.org\/10.1038\/s41467-021-23501-5 (2021).","journal-title":"Nat. Commun."},{"key":"5649_CR34","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ejphar.2019.04.018","volume":"854","author":"S Li","year":"2019","unstructured":"Li, S. et al. Dihydroartemisinin represses esophageal cancer Glycolysis by down-regulating pyruvate kinase M2. Eur. J. Pharmacol. 854, 232\u2013239. https:\/\/doi.org\/10.1016\/j.ejphar.2019.04.018 (2019).","journal-title":"Eur. J. Pharmacol."},{"key":"5649_CR35","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1074\/jbc.RA118.005963","volume":"294","author":"J Fu","year":"2019","unstructured":"Fu, J. et al. Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus. J. Biol. Chem. 294, 327\u2013340. https:\/\/doi.org\/10.1074\/jbc.RA118.005963 (2019).","journal-title":"J. Biol. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05649-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05649-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05649-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T03:42:41Z","timestamp":1751427761000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-05649-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":35,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5649"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-05649-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"28 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee of First Affiliated Hospital of Xinjiang Medical University (permission no. 20160218-123).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"23212"}}